| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.02 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |